3 Pitfalls Posed By Over-The-Counter Drug Recalls

Law360, New York (November 1, 2013, 9:20 PM EDT) -- Recalls can be trickier for over-the-counter drug makers than their prescription-drug counterparts, as the companies face a wider, more complex distribution network and a more wary U.S. Food and Drug Administration. Here, experts detail the potential pitfalls and how to navigate them.

The FDA looks for the same things during an inspection whether a facility produces painkillers to dull headaches or intravenous drugs to fight cancer, experts said. But to conduct as successful an over-the-counter drug recall as possible, attorneys should keep in mind several of...
To view the full article, register now.